logo
Legislator pushes for caffeine label law after 2022 death blamed on Charged Lemonade

Legislator pushes for caffeine label law after 2022 death blamed on Charged Lemonade

Yahoo03-04-2025

A New Jersey congressman wants to pass legislation that would increase transparency around caffeine content, three years after the death of a student with a heart condition who consumed a highly caffeinated lemonade.
Named in honor of the 21-year-old student, the Sarah Katz Caffeine Safety Act would require restaurant chains to disclose on menus and drive-thru kiosks whether a food or drink contains 150 milligrams or more of caffeine, which is about as much as is in a 16-ounce caffe latte or three cans of Diet Coke.
The bill from Rep. Rob Menendez, D-N.J., would also require energy drink companies to label the amount of caffeine and other stimulants in their beverages.
'It's simple. We want every consumer to know what they're drinking,' he said at a news conference Monday. 'These changes will ensure that everyone, no matter how old or young, can walk into a store or order off a menu and know with confidence how much caffeine is in their drink.'
The bipartisan legislation would also direct federal agencies to increase public education about the effects of caffeine and to study the way that energy drinks are marketed to young people.
Menendez introduced the bill at the end of last year. He reintroduced it this week in Katz's hometown of Jersey City, flanked by her parents and other parents who lost their children to sudden cardiac arrest.
'I think Sarah would be really proud,' her mother, Jill Katz, told NBC News on Wednesday. 'She can't help people anymore, but we can.'
Katz had been diagnosed at a young age with a genetic heart condition called Long QT syndrome, which the American Heart Association describes as a disorder of the heart's electrical system that can cause abnormal heart rhythms. It can be well-managed with medication and lifestyle changes, and Katz avoided energy drinks at her doctors' recommendation.
In September 2022, Katz bought a Charged Lemonade from a Panera Bread restaurant in Philadelphia and later went into cardiac arrest, according to a 2023 wrongful death lawsuit filed by her family that ended in a settlement with Panera last fall. A friend told NBC News that Katz would not have consumed the lemonade had she known what was in it: A large cup of the Charged Lemonade contained 390 milligrams of caffeine when served without ice, which is nearly the total daily maximum amount of 400 milligrams that the Food and Drug Administration recommends for healthy adults.
The drink also contained guarana, another stimulant commonly found in energy drinks. The Charged Lemonade was dispensed to customers side-by-side with non-caffeinated beverages at self-serve stations, the lawsuit said, which called it a 'dangerous energy drink' that Panera should have known could cause 'catastrophic injuries and/or death.'
Panera has denied wrongdoing in court documents. It instituted a number of changes following the lawsuit, including moving the Charged Lemonade behind the counter and updating its nutrition information to reflect how much caffeine was in the drink when it was served with ice. It also added prominent signs cautioning that Charged Lemonade contained caffeine, should be consumed in moderation and was not recommended for children, people sensitive to caffeine, pregnant or nursing women.
In May, the bakery-cafe chain announced it was discontinuing the beverage as part of a 'recent menu transformation.'
The lawsuit was the first of at least four that Panera ended up facing over its Charged Lemonade. A second lawsuit blamed it for a Florida man's death, while the other two alleged that the drink caused permanent heart injuries in previously healthy people. Those three lawsuits are ongoing.
Panera has stood by the safety of its products. Following the second death, it said in a statement that it felt the customer's 'unfortunate passing was not caused by one of the company's products.'
Menendez's bill is endorsed by the American Academy of Pediatrics, heart health organizations and consumer advocacy groups.
'Caffeine's reinforcing properties create powerful incentives for companies to use it in their products, at levels higher than many consumers would prefer, including for products marketed to children,' Thomas Gremillion, director of food policy at the Consumer Federation of America, said in a statement. 'The Sarah Katz Caffeine Safety Act provides a check on these perverse incentives, and allows consumers to decide how much, if any, caffeine is right for them.'
The American Beverage Association, a trade group, told NBC News that nearly all energy drink manufacturers already voluntarily abide by the association's guidelines for labeling, which includes declaring the total amount of caffeine from all sources on cans. (Ingredients such as guarana are listed in the beverage's nutrition panel.)
'For more than a decade, America's leading energy drink manufacturers have gone beyond all federal requirements when it comes to responsible labeling and marketing practices by displaying total caffeine content from all sources on labels and adhering to a long-standing commitment to not market to children,' the association said in an emailed statement.
This article was originally published on NBCNews.com

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Celebrity diagnoses underscore rising breast cancer rates in young women
Celebrity diagnoses underscore rising breast cancer rates in young women

UPI

time11 hours ago

  • UPI

Celebrity diagnoses underscore rising breast cancer rates in young women

June 9 (UPI) -- More young women in the United States are being diagnosed with breast cancer, and several celebrities have helped raise awareness by sharing their stories. Singer Jessie J, 37, said last week that she has early-stage breast cancer and will have surgery this month. "Bachelorette" star Katie Thurston, 34, is documenting her treatment for stage 4 breast cancer. Actress Danielle Fishel, 43, also shared her diagnosis last summer, NBC News said in a new report. The rise in cases reflects a national trend. Between 2012 and 2021, breast cancer rates rose 1.4% each year in women under 50, compared with 0.7% each year in those 50 and older. Rates have increased across all racial and ethnic groups, especially among Asian American and Pacific Islander women under 50. Their breast cancer rates have jumped nearly 50% since 2000. Black women are more likely than other groups to be diagnosed with breast cancer before age 40, and they are also more likely to die from the disease, NBC News said. Routine mammograms usually start at age 40, and younger women are rarely screened unless they're at high risk - such as those with a family history or certain genetic mutation. Doctors say this delay in screening can make it harder to catch breast cancer early, when it is easier to treat. "The thought was always, if you had a change in your breast but you were a young woman, it was probably nothing," said Dr. Rani Bansal of Duke University School of Medicine. "As we're seeing more and more younger women get diagnosed ... we need to take these cases seriously." Symptoms to watch for include lumps or nipple discharge. Dr. Oluwadamilola Fayanju, chief of breast surgery at Penn Medicine, said her youngest breast cancer patient was just 17. She said young women should consider getting care at a clinic that specializes in breast imaging. Experts suspect many factors may play a role, including: • Hormones • A diet high in processed foods • Obesity • Increased alcohol use • Exposure to harmful chemicals Environmental toxins like BPA and Teflon have been widely used for decades. Researchers are now studying how those early exposures might raise cancer risk later on, NBC News reported. Some studies suggest that chemical hair straighteners ---often used by Black women -- may increase breast cancer risk, possibly by affecting hormones in the body. Delaying childbirth may also play a role. Women who have babies later in life are more likely to develop postpartum breast cancer - cancers that appear within five to 10 years of giving birth. Each year, about 18,000 U.S. women are diagnosed with postpartum breast cancer, said Dr. Virginia Borges of the University of Colorado Cancer Center. Younger women are more likely to be diagnosed with triple-negative breast cancer, a fast-growing type that has fewer treatment options. Even though overall survival rates are improving, Borges said breast cancer diagnosed before age 35 often spreads more easily. Doctors are still trying to understand why. "We need more data to better tailor our treatments towards younger women," Bansal added. "A lot of the studies that are done are in older women." Experts suggest that women who are at higher risk begin screenings as early as age 30. This may include yearly mammograms and breast MRIs. More information The American Cancer Society has more on breast cancer screening guidelines. Copyright © 2025 HealthDay. All rights reserved.

Nano-Cap PolyPid's Lead Drug Candidate Cuts Surgical Infection Risk by 38% In Phase 3 Trial
Nano-Cap PolyPid's Lead Drug Candidate Cuts Surgical Infection Risk by 38% In Phase 3 Trial

Yahoo

time11 hours ago

  • Yahoo

Nano-Cap PolyPid's Lead Drug Candidate Cuts Surgical Infection Risk by 38% In Phase 3 Trial

PolyPid Ltd. (NASDAQ:PYPD) on Monday announced topline results from its pivotal SHIELD II Phase 3 trial of D-PLEX100 to prevent surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. The SHIELD II trial is designed to assess the efficacy and safety of D-PLEX100 administered concomitantly with the standard of care (SoC), which includes prophylactic systemic antibiotics, compared to the SoC alone arm in the prevention of post-abdominal-surgery incisional infection in patients undergoing abdominal colorectal surgeries with large incisions. The trial's primary endpoint is measured by the proportion of subjects with a surgical site infection or mortality for any reason within 30 days post-surgery. FDA Pushes Pause On Axsome Fibromyalgia Drug, New Trial Required Patient safety will be monitored for an additional 30 days. The trial will enroll patients in centers in the United States, Europe, and Israel. D-PLEX100, PolyPid's lead product candidate, is designed to provide local, prolonged, and controlled antibacterial activity directly at the surgical site to prevent SSIs. Following the administration of D-PLEX100 into the surgical site, the PLEX (Polymer-Lipid Encapsulation matriX) technology pairs with Active Pharmaceutical Ingredients, enabling a prolonged and continuous release of the broad-spectrum antibiotic doxycycline, resulting in a high local concentration of the drug for 30 days for the prevention of SSIs, with additional potential to prevent SSIs caused by antibiotic-resistant bacteria at the surgical site. The trial met the primary efficacy endpoint, with a significantly lower proportion of primary endpoint events among patients who received D-PLEX100 plus SoC (n=405; 10.9%), compared to SoC alone (n=393; 18.1%), representing a 38% reduction (p<0.005). SHIELD II included three key secondary endpoints: The first key secondary endpoint was met, with a 58% reduction in deep and superficial SSI rates among patients who received D-PLEX100 plus SoC (3.8%) compared to those who received SoC alone (9.5%) (p<0.005). The second key secondary endpoint showed statistical significance in favor of D-PLEX100 plus SoC over SoC alone (p<0.005). The third key secondary endpoint was met with a 62% reduction of patients with an ASEPSIS1 score >20 in the D-PLEX100 plus SoC arm compared to the SoC alone arm (p<0.05). The ASEPSIS score is a clinical tool used to assess surgical wound infections objectively. The independent Data Safety Monitoring Board raised no safety concerns in SHIELD II. The company expects to submit a New Drug Application to the U.S. Food and Drug Administration in early 2026, with a Marketing Authorization Application in the E.U. to follow shortly thereafter. Price Action: PYPD stock is trading higher by 12% to $3.66 at last check Monday. Read Next:Photo by ittawit21 via Shutterstock Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? This article Nano-Cap PolyPid's Lead Drug Candidate Cuts Surgical Infection Risk by 38% In Phase 3 Trial originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved.

VA Marks Benefits Milestone For Veterans
VA Marks Benefits Milestone For Veterans

Miami Herald

time13 hours ago

  • Miami Herald

VA Marks Benefits Milestone For Veterans

The Department of Veterans Affairs (VA) has announced that its mobile app has now accumulated more than 3 million downloads since its launch in 2021. The Health and Benefits app, which has 1.4 million active users, provides veterans access to information on health care and benefits. It allows users to refill and track VA prescriptions, review appointments, review claims and appeals status, submit evidence for claims and appeals, review VA payment and direct deposit information, locate the closest VA facilities, access the Veterans Crisis Line and show proof of Veteran status. VA Acting Assistant Secretary for Information and Technology and Acting Chief Information Officer Eddie Pool said: "VA's Health and Benefits app gives Veterans fast and convenient access to a host of important information, from appointments to prescriptions and benefits. We encourage all VA-enrolled Veterans to stay connected and informed by downloading the app." This story will be updated. Related Articles How Veteran's Benefits Are Impacted by Trump's Tax Bill: What to KnowHegseth Joins Veterans in Normandy to Mark 81st Anniversary of D-DayList of Cities Hosting 50501 Protests on June 6Harvey Milk Navy Ship To Be Renamed-Vets Call It 'Insult to LGBTQ Troops' 2025 NEWSWEEK DIGITAL LLC.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store